ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...

Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has ...

Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

Salk scientists link bile acids and immune cell performance in liver cancer, finding that supplementing the bile acid UDCA—already a current treatment for liver disease—and inhibiting bile ...

Adding a PD-1 antibody to BCG led to improved event-free survival in patients with non–muscle invasive bladder cancer.

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

Artificial intelligence predicts the outcomes of cancer treatments. The melding of visual information (microscopic and X-ray ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...